Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 433

1.

Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.

Tomlinson A, Efthimiou O, Boaden K, New E, Mather S, Salanti G, Imai H, Ogawa Y, Tajika A, Kishimoto S, Kikuchi S, Chevance A, Furukawa TA, Cipriani A.

Evid Based Ment Health. 2019 Apr 17. pii: ebmental-2019-300087. doi: 10.1136/ebmental-2019-300087. [Epub ahead of print]

PMID:
30996028
2.

Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression: A Network Meta-analysis.

Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA.

JAMA Psychiatry. 2019 Apr 17. doi: 10.1001/jamapsychiatry.2019.0268. [Epub ahead of print]

PMID:
30994877
3.

The association between patients' feedback comments and the depressive mood, satisfaction, homework conducted, and dropouts during self-guided smartphone cognitive behavioral therapy.

Imai H, Takeshima N, Hayasaka Y, Yonemoto N, Ogawa Y, Tajika A, Fujita H, Kato T, Furukawa TA; FLATT investigators.

Psychiatry Clin Neurosci. 2019 Apr 9. doi: 10.1111/pcn.12849. [Epub ahead of print]

PMID:
30968499
4.

Further evidence that item responses on the Kessler Psychological Distress Scale exhibit the characteristic pattern in the general population.

Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Ono Y, Furukawa TA.

Heliyon. 2019 Mar 21;5(3):e01387. doi: 10.1016/j.heliyon.2019.e01387. eCollection 2019 Mar.

5.

Brief mindfulness-based stress management program for a better mental state in working populations - Happy Nurse Project: A randomized controlled trial✰✰.

Watanabe N, Horikoshi M, Shinmei I, Oe Y, Narisawa T, Kumachi M, Matsuoka Y, Hamazaki K, Furukawa TA.

J Affect Disord. 2019 Mar 22;251:186-194. doi: 10.1016/j.jad.2019.03.067. [Epub ahead of print]

PMID:
30927579
6.

Benzodiazepines versus placebo for panic disorder in adults.

Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJ, Furukawa TA, Koesters M.

Cochrane Database Syst Rev. 2019 Mar 28;3:CD010677. doi: 10.1002/14651858.CD010677.pub2.

PMID:
30921478
7.

Cohort Profile: The Tokyo Teen Cohort study (TTC).

Ando S, Nishida A, Yamasaki S, Koike S, Morimoto Y, Hoshino A, Kanata S, Fujikawa S, Endo K, Usami S, Furukawa TA, Hiraiwa-Hasegawa M, Kasai K; TTC Scientific and Data Collection Team.

Int J Epidemiol. 2019 Mar 16. pii: dyz033. doi: 10.1093/ije/dyz033. [Epub ahead of print] No abstract available.

PMID:
30879075
8.

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.

Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A.

J Affect Disord. 2019 May 1;250:419-424. doi: 10.1016/j.jad.2019.03.031. Epub 2019 Mar 6.

PMID:
30878654
9.

Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking.

Furukawa TA, Reijnders M, Kishimoto S, Sakata M, DeRubeis RJ, Dimidjian S, Dozois DJA, Hegerl U, Hollon SD, Jarrett RB, Lespérance F, Segal ZV, Mohr DC, Simons AD, Quilty LC, Reynolds CF, Gentili C, Leucht S, Engel RR, Cuijpers P.

Epidemiol Psychiatr Sci. 2019 Mar 14:1-13. doi: 10.1017/S2045796019000088. [Epub ahead of print]

PMID:
30867082
10.

Predicting relapse in major depression after successful initial pharmacological treatment.

Akechi T, Mantani A, Kurata K, Hirota S, Shimodera S, Yamada M, Inagaki M, Watanabe N, Kato T, Furukawa TA; SUND Investigators.

J Affect Disord. 2019 May 1;250:108-113. doi: 10.1016/j.jad.2019.03.004. Epub 2019 Mar 5.

PMID:
30851699
11.

Dismantling, personalising and optimising internet cognitive-behavioural therapy for depression: a study protocol for individual participant data component network meta-analysis.

Furukawa TA, Karyotaki E, Suganuma A, Pompoli A, Ostinelli EG, Cipriani A, Cuijpers P, Efthimiou O.

BMJ Open. 2019 Feb 22;8(11):e026137. doi: 10.1136/bmjopen-2018-026137.

12.

Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study.

Imai F, Momino K, Katsuki F, Horikoshi M, Furukawa TA, Kondo N, Toyama T, Yamaguchi T, Akechi T.

Jpn J Clin Oncol. 2019 Feb 22. pii: hyz005. doi: 10.1093/jjco/hyz005. [Epub ahead of print]

PMID:
30793156
13.

Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models.

Noma H, Maruo K, Gosho M, Levine SZ, Goldberg Y, Leucht S, Furukawa TA.

BMC Med Res Methodol. 2019 Feb 14;19(1):33. doi: 10.1186/s12874-019-0676-1.

14.

Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov.

Takeshima N, Ishiwata K, Sozu T, Furukawa TA.

Alzheimer Dis Assoc Disord. 2019 Feb 5. doi: 10.1097/WAD.0000000000000297. [Epub ahead of print]

PMID:
30730347
15.

Physician characteristics associated with proper assessment of overstated conclusions in research abstracts: A secondary analysis of a randomized controlled trial.

Tsujimoto Y, Aoki T, Shinohara K, So R, Suganuma AM, Kimachi M, Yamamoto Y, Furukawa TA.

PLoS One. 2019 Jan 25;14(1):e0211206. doi: 10.1371/journal.pone.0211206. eCollection 2019.

16.

Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data.

Shinohara K, Tanaka S, Imai H, Noma H, Maruo K, Cipriani A, Yamawaki S, Furukawa TA.

Evid Based Ment Health. 2019 Feb;22(1):10-16. doi: 10.1136/ebmental-2018-300073. Epub 2019 Jan 21.

PMID:
30665989
17.

Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.

Yamamoto-Sasaki M, Yoshida S, Takeuchi M, Tanaka-Mizuno S, Ogawa Y, Furukawa TA, Kawakami K.

Matern Health Neonatol Perinatol. 2019 Jan 10;5:1. doi: 10.1186/s40748-018-0096-y. eCollection 2019.

18.

Maternal diabetes in early pregnancy, and psychotic experiences and depressive symptoms in 10-year-old offspring: A population-based birth cohort study.

Yamasaki S, Ando S, Richards M, Hatch SL, Koike S, Fujikawa S, Kanata S, Endo K, Morimoto Y, Arai M, Okado H, Usami S, Furukawa TA, Hiraiwa-Hasegawa M, Kasai K, Nishida A.

Schizophr Res. 2018 Dec 26. pii: S0920-9964(18)30704-7. doi: 10.1016/j.schres.2018.12.016. [Epub ahead of print]

19.

Response inhibition and anxiety in adolescents: Results from a population-based community sample.

Iijima Y, Okumura Y, Yamasaki S, Ando S, Nakanishi M, Koike S, Endo K, Morimoto Y, Kanata S, Fujikawa S, Yamamoto Y, Furukawa TA, Hiraiwa-Hasegawa M, Kasai K, Nishida A.

J Affect Disord. 2019 Mar 1;246:89-95. doi: 10.1016/j.jad.2018.12.010. Epub 2018 Dec 10.

PMID:
30578951
20.

Predictors of hypomanic and/or manic switch among patients initially diagnosed with unipolar major depression during acute-phase antidepressants treatment.

Akechi T, Kato T, Watanabe N, Tanaka S, Furukawa TA; SUN☺D Investigators.

Psychiatry Clin Neurosci. 2019 Feb;73(2):90-91. doi: 10.1111/pcn.12808. Epub 2019 Jan 6. No abstract available.

PMID:
30537349

Supplemental Content

Loading ...
Support Center